Improved Outcomes with “7+3” Induction Chemotherapy for Acute Myeloid Leukemia over the Past Four Decades: Analysis of SWOG Trial Data

To evaluate how the length of the first complete response has changed over this time period, researchers analyzed 1,247 patients aged 65 or younger randomized to “7+3” arms from five SWOG studies.